Everolimus
Orphan DrugFDA Approved
Contents
Description
Everolimus is a kinase inhibitor used in the treatment of kidney clear cell carcinoma. It works by inhibiting mTOR, a protein that regulates cell growth and proliferation. Everolimus is available as an oral tablet.
Indications & Therapeutic Use
Kidney clear cell sarcoma
Global Availability (5 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Everolimus — GNH India
267 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Aderolio
EU
Aderolio 250 Mcg Tablets
EU
Aderolio 500 Mcg Tablets
EU
Afinitor
EU
Afinitor 10
10mg
AFINITOR DISPERZ
2 MGtablet for suspensionCANADA
AFINITOR-10mg
5mgtabletAustralia
AFINITOR-5mg
5mgtabletAustralia
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Everolimus
| Generic Name | Everolimus |
| Brands | 1 brand available |
| Active Ingredient | Everolimus |
| Drug Class | Kidney clear cell sarcoma |
| Manufacturer | Novartris |
| Dosage Forms | Oral tablet |
| Medical Code | L01EH01 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Not Required |
| Reg. Status | FDA Approved |
| Countries | 5 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations6 Validated Nodes